Omalizumab for severe allergic keratoconjunctivitis: A case series-Reference-Cited by-同舟云学术

Omalizumab for severe allergic keratoconjunctivitis: A case series

Published:2023-11 Issue:11 Volume:11 Page:3528-3530
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Mercier Marie,Doan Serge,Elaouane Imane,Chelly Zied,Bourgoin-Heck Mélisande,Lambert Nathalie,Cottel Nathalie,Taillé Camille,Wanin Stéphanie^ORCID

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference9 articles.

1. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes;Vichyanond;Pediatr Allergy Immunol,2014

2. Diagnosis, management, and treatment of vernal keratoconjunctivitis in Asia: recommendations from the Management of Vernal Keratoconjunctivitis in Asia Expert Working Group;Mehta;Front Med (Lausanne),2022

3. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup;Bonini;Ophthalmology,2000

4. Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients;Leonardi;Allergy,2009

5. Omalizumab treatment of vernal keratoconjunctivitis;Heffler;JAMA Ophthalmol,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the complexity – Insights and interventions of refractory vernal keratoconjunctivitis;The Ocular Surface;2024-10

2. Anti‐interleukin 5 for treating severe refractory vernal keratoconjunctivitis in children: Two cases;Pediatric Allergy and Immunology;2024-05